I found this on Facebook tonight. Another article referring to the effectiveness of immunotherapy drug Opdivo which has been approved for use in New Zealand but not for head and neck cancer - yet.
http://www.telegraph.co.uk/science/2016/04/19/drug-doubles-chance-of-surviving-head-and-neck-cancer-for-a-year/?cid=sf24650168&sf24650168=1
No comments:
Post a Comment